Cerevel Therapeutics
CERE
#1975
Rank
S$10.66 B
Marketcap
$58.56
Share price
0.00%
Change (1 day)
105.98%
Change (1 year)

EPS for Cerevel Therapeutics (CERE)

EPS in 2023 (TTM): -$3.37

According to Cerevel Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.26. In 2022 the company made an earnings per share (EPS) of -$3.02 a decrease over its 2021 EPS that were of -$2.15.

EPS history for Cerevel Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$3.3711.42%
2022-$3.0240.61%
2021-$2.1536.84%
2020-$1.57

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$9.40-388.52%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.40-173.60%๐Ÿ‡บ๐Ÿ‡ธ USA
$12.62-487.60%๐Ÿ‡บ๐Ÿ‡ธ USA
$3.75-215.20%๐Ÿ‡บ๐Ÿ‡ธ USA